SARS-COV-2 INFECTION IN PATIENS WITH CHRONIC DISEASES
Abstract
SARS-CoV-2 infection (COVID-19) is characterized by a variety of clinical symptoms. The manifestation and course of the disease depend on many factors, including the patient's age, sex, and comorbidities. Research has shown that COVID-19 in patients with chronic diseases is mainly manifested by systemic symptoms such as fever, weakness, and pain. From different types of acute pain, headache is the most prevalent symptom, it is characterized by a long course and severity. Chronic patients often experience a variety of complications, including bronchopneumonia, which, in 27% of patients, developed and became one of the leading causes of hospitalization. Such complications may later become a risk factor for the development of prolonged COVID-19, or Post-Covid Syndrome. COVID-19 directly and indirectly affects chronic diseases themselves and complicates their management and prevention. In this regard, it is necessary to train family physicians in patients with chronic diseases infected with SARS-CoV-2 in order to timely identify risk factors for the complication of infection and the development of Post-Covid syndrome and to prevent their impact.
Downloads
References
Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw Open 2020;3(12):e2029058. Erratum in: JAMA Netw Open 2021;1:e2036103[REMOVED IF= FIELD] CrossRefexternal icon
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584(7821):430–6. CrossRefexternal icon
Centers for Disease Control and Prevention. People with certain medical conditions. Upd. March 29,
Karen A. Hacker, MD, MPH1; Peter A. Briss, MD, MPH1; Lisa Richardson, MD, MPH1; Janet Wright, MD1; Ruth Petersen, COVID-19 and Chronic Disease: The Impact Now and in the Future ESSAY — Volume 18 — June 17, 2021. https://www.cdc.gov/pcd/issues/2021/21_0086.htm
N. Ninashvili, M. Shavdia - Headache prevalence in COVID-19 ambulatory patients. Cephalalgia 2021, Vol. 41(1S) 1–228. p.111.
https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Accessed April 8, 2021.
Covid-19 and people with chronic conditions. https://www.lshtm.ac.uk/research/centres/centre-global-chronic-conditions/covid-19-and-people-chronic-conditions
Kavita Singh, Aprajita Kaushik, Leslie Johnson, Suganthi Jaganathan, Prashant Jarhyan, Mohan Deepa4, Sandra Kong5, hNikhil Srinivasapura Venkateshmurthy, Dimple Kondal, Sailesh Mohan, Ranjit Mohan Anjana, Mohammed K Ali, Nikhil Tandon, K M Venkat Narayan, Viswanathan Mohan, Karen Eggleston, Dorairaj Prabhakaran. Patient experiences and perceptions of chronic disease care during the COVID-19 pandemic in India: a qualitative study. https://bmjopen.bmj.com/content/11/6/e048926
Shatha K Alyammahi, Shifaa M Abdin , Dima W Alhamad , Sara M Elgendy, Amani T Altell , Hany A Omar. The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities. Infect Genet Evol. 2021 Jan;87:104647. DOI: 10.1016/j.meegid.2020.104647. https://pubmed.ncbi.nlm.nih.gov/33264669/
JinSong Geng, XiaoLan Yu, HaiNi Bao, Zhe Feng, XiaoYu Yuan, JiaYing Zhang, XiaoWei Chen, YaLan Chen, ChengLong Li ,Hao Yu. Chronic Diseases as a Predictor for Severity and Mortality of COVID-19: A Systematic Review with Cumulative Meta-Analysis. Front. Med., 01 September 2021 | https://doi.org/10.3389/fmed.2021.588013
Laure Semenzato, Jeremie Botton, Jerome Drouin, Francios Cuenot, Rosemary Dray-Spira, Alan Well, Mahmoud Zureik. Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(21)00135-6/fulltext
